The PQA Postdoctoral Fellowship serves to produce the next generation of leaders in healthcare quality through a full-time, 12-month program based in the thriving Washington, D.C. metropolitan area. The fellows collaborate with a wide variety of stakeholders at a national level to impact the quality of care patients receive with an emphasis on the quality of medication use.
The quality of oral anticancer medication (OAM) use impacts clinical care, care coordination, patient safety, and outcomes, including disparities in care, patient and caregiver experience, population health, and total health care costs. To monitor the quality of OAM use, measures assessing the degree to which patients take OAMs as prescribed was the number one measurement priority rated by 23 national experts and patients convened by PQA in 2022-2023.
Welcome to Five For Friday!
The Centers for Medicare & Medicaid Services (CMS) hosted a special expanded Open Door Forum on April 24, 2006, to publicly announce, support and promote high-value pharmacy services, including measurement approaches, through a stakeholder-led Pharmacy Quality Alliance (PQA).
Welcome to Five For Friday!
PQA has appointed 18 individuals to serve on a measure development technical expert panel (TEP) to support the development of a new health plan measure: Evidence of Guideline-Directed Medical Therapy in Persons with Heart Failure. This measure will assess the percentage of individuals with prescription claims for guideline-directed medical therapies for the treatment of heart failure.
The Pharmacy Quality Alliance was born from a collaboration. In 2006, when Medicare Part D was launched, Centers for Medicare & Medicaid Services (CMS) Administrator Mark McClellan had a vision to not simply cover seniors’ medication costs, but to pay for high value-care.
When quality measures are used for performance comparisons within national programs, they should meet the measure evaluation criteria of importance, feasibility, scientific acceptability and usability. To satisfy importance criterion, evidence should demonstrate that the process of care meaningfully affects the desired outcome. PQA upholds these established standards for performance measure development, including sufficient evidence of the impact of the process of care on the desired outcome.
This guest blog is one in a series by sponsors of the PQA Annual Meeting on improving patient outcomes through pharmacy models. PQA does not endorse, recommend or favor any product, service or organization that is a sponsor.
PQA is celebrating its 20th year in 2026. In addition to special events at the 2026 PQA Annual Meeting in Baltimore, Md., May 12-14, PQA will recognize across the year the people, milestones and achievements that have defined the organization’s success. We also will look to the future and PQA’s continuing work to improve the quality of medication use.
Artificial intelligence (AI) is reshaping health care, including how medications are used. On November 13, 2025, PQA hosted PQA Convenes: Artificial Intelligence in Medication Use Quality to bring together PQA members, health technology leaders, and other stakeholders for a discussion on how AI and machine learning are being used to identify, understand, and engage patients in their medication use.
Welcome to Five For Friday!
The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.
Artificial intelligence (AI) is reshaping health care, including how medications are used. On November 13, 2025, PQA hosted PQA Convenes: Artificial Intelligence in Medication Use Quality to bring together PQA members, health technology leaders, and other stakeholders for a discussion on how AI and machine learning are being used to identify, understand, and engage patients in their medication use.
PQA has appointed 16 individuals to serve on a new Patient Advisory Council. The council will advise PQA on what matters most to patients, their families and caregivers as it relates to safe, effective and appropriate medication use. The council also will provide input on strategies to meaningfully incorporate patient perspectives throughout PQA’s work to improve the quality of medication use and patient outcomes.
PQA is celebrating its 20th year in 2026. In addition to special events at the 2026 PQA Annual Meeting in Baltimore, Md., May 12-14, PQA will recognize across the year the people, milestones and achievements that have defined the organization’s success. We also will look to the future and PQA’s continuing work to improve the quality of medication use.
Artificial intelligence (AI) is reshaping health care, including how medications are used. On November 13, 2025, PQA hosted PQA Convenes: Artificial Intelligence in Medication Use Quality to bring together PQA members, health technology leaders, and other stakeholders for a discussion on how AI and machine learning are being used to identify, understand, and engage patients in their medication use.
Welcome to Five For Friday!
PQA is celebrating its 20th year in 2026. In addition to special events at the 2026 PQA Annual Meeting in Baltimore, Md., May 12-14, PQA will recognize across the year the people, milestones and achievements that have defined the organization’s success. We also will look to the future and PQA’s continuing work to improve the quality of medication use.
In 2026, the Pharmacy Quality Alliance (PQA) marks an extraordinary milestone: 20 years of advancing medication use quality and improving patient outcomes across the United States.
